Androgen regulates ADAMTS15 gene expression in prostate cancer cells.

Androgen regulates ADAMTS15 gene expression in prostate cancer cells.

Prostate cancer is a major cause of mortality, largely as a consequence of metastases and transformation to androgen-independent growth. Metalloproteinases are implicated in cancer progression. A disintegrin and metalloproteinase with thrombospondin motifs (ADAMTS) are expressed in prostate cancer c...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak:	Molokwu, C, Adeniji, O, Chandrasekharan, S, Hamdy, F, Buttle, D
Formatua:	Journal article
Hizkuntza:	English
Argitaratua:	2010

Antzeko izenburuak

Regulation of ADAMTS15 by dihydrotestosterone in prostate cancer cells and identification of putative androgen response elements
nork: Molokwu, C, et al.
Argitaratua: (2009)

Regulation of ADAMTS expression in prostate cancer and stromal cells by androgen and TNF
nork: Molokwu, C, et al.
Argitaratua: (2007)

TIMP-3 expression is regulated by androgen and TNF in prostate stromal and cancer cells
nork: Adeniji, O, et al.
Argitaratua: (2008)

TIMP-3 expression in prostate stromal and tumour cells is regulated by androgen and TNF
nork: Adeniji, O, et al.
Argitaratua: (2007)

Evaluating the role of ADAMTS proteoglycanases and TIMP-3 in prostate cancer progression
nork: Adeniji, O, et al.
Argitaratua: (2007)

Analysis of the functional role of ADAMTS enzymes in prostate cancer
nork: Molokwu, C, et al.
Argitaratua: (2005)

Imaging proteolysis in prostate cancer and stromal cells
nork: Molokwu, C, et al.
Argitaratua: (2007)

The expression and regulation of ADAMTS-1, -4, -5, -9, and -15, and TIMP-3 by TGFbeta1 in prostate cells: relevance to the accumulation of versican.
nork: Cross, N, et al.
Argitaratua: (2005)

Expression pattern of the ADAMTS (A Disintegrin And Metalloproteinase with ThromboSpondin motifs) proteinases in human prostate cancer celllines
nork: Chandrasekharan, S, et al.
Argitaratua: (2003)

Androgens target prohibitin to regulate proliferation of prostate cancer cells.
nork: Gamble, S, et al.
Argitaratua: (2004)

NF-kappaB regulates androgen receptor expression and prostate cancer growth.
nork: Zhang, L, et al.
Argitaratua: (2009)

Glycosylation is an androgen-regulated process essential for prostate cancer cell viability.
nork: Munkley, J, et al.
Argitaratua: (2016)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
nork: Hamdy, F
Argitaratua: (2005)

ANTI-ANDROGENS IN TREATMENT OF PROSTATE-CANCER - REPLY
nork: Dalesio, O, et al.
Argitaratua: (1995)

Androgen blockade in prostate cancer - Authors' reply
nork: Dalesio, O, et al.
Argitaratua: (2000)

Anticancer imidazoacridinone C-1311 is effective in androgen-dependent and androgen-independent prostate cancer cells
nork: Niemira, M, et al.
Argitaratua: (2020)

Mechanism of anti-cancer activity of curcumin on androgen-dependent and androgen-independent prostate cancer
nork: Abd. Wahab, Nurul Azwa, et al.
Argitaratua: (2020)

Drivers of AR indifferent anti-androgen resistance in prostate cancer cells.
nork: Handle, F, et al.
Argitaratua: (2019)

Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
nork: Banham, A, et al.
Argitaratua: (2007)

The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells
nork: Wilson, S, et al.
Argitaratua: (2017)

Sequencing the transcriptional network of androgen receptor in prostate cancer
nork: Chng, Kern Rei, et al.
Argitaratua: (2013)

Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines.
nork: Shaida, N, et al.
Argitaratua: (2008)

Androgen manipulation alters oxidative DNA adduct levels in androgen-sensitive prostate cancer cells grown in vitro and in vivo.
nork: Pathak, S, et al.
Argitaratua: (2008)

The early effects of rapid androgen deprivation on human prostate cancer
nork: Shaw, G, et al.
Argitaratua: (2015)

Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells
nork: Fontanil, T, et al.
Argitaratua: (2017)

Anti-androgens regulate amino acid-mTORC1 signalling and extracellular vesicle secretion to modulate prostate cancer progression
nork: McCormick, K, et al.
Argitaratua: (2019)

Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
nork: Dalesio, O, et al.
Argitaratua: (2000)

Impact of TMPRSS2-ERG fusion gene on prostate cancer cell response to chemotherapy, radiotherapy and androgen deprivation therapy
nork: Ovtcharov, S
Argitaratua: (2015)

Engineering and expression of ADAMTS-4 and ADAMTS-5, proteolytic enzymes involved in osteoarthritis progression
nork: Lauer-Fields, J, et al.
Argitaratua: (2005)

Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
nork: Eaton, C, et al.
Argitaratua: (2004)

Emerging frontiers in androgen receptor research for prostate Cancer: insights from the 2nd international androgen receptor Symposium
nork: Israel, JS, et al.
Argitaratua: (2024)

Independence of HIF1a and androgen signaling pathways in prostate cancer
nork: Tran, MGB, et al.
Argitaratua: (2020)

c-Myc antagonises the transcriptional activity of the androgen receptor in prostate cancer affecting key gene networks.
nork: Barfeld, S, et al.
Argitaratua: (2017)

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
nork: Rajan, P, et al.
Argitaratua: (2014)

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy
nork: Rajan, P, et al.
Argitaratua: (2014)

Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.
nork: Asim, M, et al.
Argitaratua: (2017)

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
nork: Dahlman, A, et al.
Argitaratua: (2010)

Androgen receptor deregulation drives bromodomain-mediated chromatin alterations in prostate cancer.
nork: Urbanucci, A, et al.
Argitaratua: (2017)

FUS/TLS is a novel mediator of androgen-dependent cell-cycle progression and prostate cancer growth.
nork: Brooke, G, et al.
Argitaratua: (2011)

Bone marrow stromal cell-derived insulin-like growth factor (IGF) II enhances growth and survival of prostate cancer cells and potentiates androgen action
nork: Cross, N, et al.
Argitaratua: (2007)